These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 1921687

  • 1. [Cytologic changes in bronchoalveolar lavage in amiodarone treated patients].
    Jolly E, Belloti MS, Lowenstein J, Luna C, Avagnina A, Elsner B, Mazzei JA.
    Medicina (B Aires); 1991; 51(1):19-25. PubMed ID: 1921687
    [Abstract] [Full Text] [Related]

  • 2. [Pulmonary toxicity of amiodarone].
    Sevillano Martín C, Callol Sánchez L, Calderón Alvarez J, Moreno Muro M, Gómez de Terreros FJ.
    Rev Clin Esp; 1989 Nov; 185(7):362-5. PubMed ID: 2623252
    [Abstract] [Full Text] [Related]

  • 3. Amiodarone pulmonary toxicity: clinical and subclinical features.
    Adams PC, Gibson GJ, Morley AR, Wright AJ, Corris PA, Reid DS, Campbell RW.
    Q J Med; 1986 May; 59(229):449-71. PubMed ID: 3763811
    [Abstract] [Full Text] [Related]

  • 4. Amiodarone pulmonary toxicity. Clinical, cytologic and ultrastructural findings.
    Stein B, Zaatari GS, Pine JR.
    Acta Cytol; 1987 May; 31(3):357-61. PubMed ID: 3473872
    [Abstract] [Full Text] [Related]

  • 5. [Pneumonitis induced by amiodarone].
    Terra Filho M, Vargas FS, Cukier A, Teixeira LR, Pinto RM, Pileggi F.
    Arq Bras Cardiol; 1989 Oct; 53(4):201-5. PubMed ID: 2483501
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Amiodarone pulmonary toxicity: biochemical evidence for a cellular phospholipidosis in the bronchoalveolar lavage of human subjects.
    Martin WJ, Standing JE.
    J Pharmacol Exp Ther; 1988 Feb; 244(2):774-9. PubMed ID: 3346847
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Broncho-alveolar lavage in pulmonary involvement in rheumatoid arthritis].
    Herer B, De Castelbajac D, Israel-Biet D, Venet A, Huchon G, Chrétien J.
    Ann Med Interne (Paris); 1988 Feb; 139(5):310-4. PubMed ID: 3202531
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. NTP Toxicology and Carcinogenesis Studies of Talc (CAS No. 14807-96-6)(Non-Asbestiform) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 421():1-287. PubMed ID: 12616290
    [Abstract] [Full Text] [Related]

  • 17. [Mast cells in bronchoalveolar lavage fluid of patients with interstitial lung diseases].
    Schildge J, Klar B, Hardung-Backes M.
    Pneumologie; 2003 Apr; 57(4):202-7. PubMed ID: 12690558
    [Abstract] [Full Text] [Related]

  • 18. Amiodarone pulmonary toxicity: a multidisciplinary review of current status.
    Fraire AE, Guntupalli KK, Greenberg SD, Cartwright J, Chasen MH.
    South Med J; 1993 Jan; 86(1):67-77. PubMed ID: 8420020
    [Abstract] [Full Text] [Related]

  • 19. Long term efficacy and toxicity of amiodarone in the treatment of refractory cardiac arrhythmias.
    Primeau R, Agha A, Giorgi C, Shenasa M, Nadeau R.
    Can J Cardiol; 1989 Mar; 5(2):98-104. PubMed ID: 2706579
    [Abstract] [Full Text] [Related]

  • 20. Persistence of abnormal bronchoalveolar lavage findings after cyclophosphamide treatment in scleroderma patients with interstitial lung disease.
    Mittoo S, Wigley FM, Wise R, Xiao H, Hummers L.
    Arthritis Rheum; 2007 Dec; 56(12):4195-202. PubMed ID: 18050251
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.